Disease | multiple endocrine neoplasia type 1 |
Comorbidity | C0206526|multidrug-resistant tuberculosis |
Sentences | 1 |
PubMedID- 25404020 | It is approved in several countries, including japan and those of the eu, for use as part of an appropriate combination regimen in adults with multidrug-resistant tuberculosis (mdr-tb) when an effective treatment regimen cannot otherwise be composed due to resistance or tolerability. |
Page: 1